Journal Overview

Metabolism and Target Organ Damage (M&TOD) focuses on metabolic disorders and their associations with target-organ injury, particularly affecting the cardiovascular system, liver, kidneys, and pancreas. The journal welcomes basic, clinical, and translational research on obesity, diabetes, dyslipidemia, hypertension, hyperuricemia, and related metabolic conditions, covering disease mechanisms, epidemiology, prevention, biomarkers, diagnosis, prognosis, and innovative therapeutic strategies. M&TOD also encourages interdisciplinary research involving public health, precision medicine, artificial intelligence, animal-free research models, and translational approaches that bridge basic science and clinical practice, with the aim of advancing the understanding, prevention, and management of metabolic diseases and their associated organ damage.

Reviewers whose reports are timely and of high quality receive an APC discount voucher for a future publication in an OAE journal. Become a reviewer.